Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2009
August 3, 2009
- Repros Therapeutics Inc. Suspends Dosing of Proellex and Provides Update on Financial Status
- U.S. District Court Issues in Favor of Daiichi Sankyo Regarding Patent Litigation for Benicar, Benicar HCT and Azor
- Nycomed to Acquire Local Portfolio from Sanofi-Aventis and Zentiva
- European Medicines Agency and U.S. Food and Drug Administration (FDA) launch Good Clinical Practice Initiative
August 4, 2009
- MedWatch - Botox and Botox Cosmetic and Myobloc:changes to drug names to reinforce individual potencies and prevent medication errors, recommendations for healthcare professionals to consider, information for patients, family members
- Antidepressant Use Increasing In the United States
- Lilly, Chao Center, PDA partner with Russian officials to improve quality of global drug manufacturing, distribution
- Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
- MedWatch - Tumor Necrosis Factor (TNF) Blockers: Boxed Warning describing increased risk of lymphoma in children, adolescents treated with TNF blockers
August 5, 2009
- Anesiva, Inc. and Arcion Therapeutics Announce Merger Agreement
- Dynavax Announces Path for HEPLISAV Hepatitis B Vaccine Development
- Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe)
- Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
- FDA: Cancer Warnings Required for TNF Blockers
- Withdrawal Of The Marketing Authorisation In The European Union
- The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.
- Teva Announces Appeals Court Ruling Affirming Invalidation of Yasmin Patent
August 6, 2009
- King Pharmaceuticals Reports Second Quarter 2009 Financial Results
- Med Ad News? PharmaMed Marketing & Media Conference Announces Updates to the Three Innovative Sales-Force-Effectiveness, Digital Marketing & Patient Centered Communication Tracks
- NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer
- Pharmaceutical & Medical Packaging News Launches New Website Featuring Breaking News & More Industry Resources For Healthcare Packaging Professionals
- U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic
- Baxter Completes Production of First Commercial Batches of A/H1N1 Pandemic Vaccine
- Elan Files Declaratory Suit Against Biogen Idec; Company Has Not Breached Tysabri Collaboration Agreement
- Vernalis and GlaxoSmithKline Enter Into a Collaboration, Option and License Agreement Over a Novel Vernalis Oncology Programme
August 7, 2009
- Active Biotech (SE) - New information regarding RhuDex
- Antisoma plc (UK) - Antisoma Announces Discontinuation of Development of AS1402
- FDA Commissioner Sets Out Vision on Enforcement to Support Public Health
- FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination
- Merck Shareholders Approve Merger With Schering-Plough
- Nabi Biopharmaceuticals Announces Sale of PentaStaph to GlaxoSmithKline PLC
- Alzheimer's Drug Discovery Foundation-Funded PharmatrophiX Reaches Major Milestone
August 10, 2009
August 11, 2009
- Astellas Seeks Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
- Novartis International AG (CH) - Sandoz Launches First Generic Version of Prograf Capsules
- Statement on Fosamax (alendronate sodium) Product Liability Trial in U.S. District Court
August 12, 2009
- Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of Clarinex
- Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes
- Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Medarex, Inc.
August 13, 2009
- FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
- Stada Chief Financial Officer departs
- STADA with development as planned in H1/2009: Sales: EUR 755.2 million, net income EUR 48.3 million ? outlook confirmed
- Update on Astellas' Complaint Challenging the FDA's Decision for Citizen Petition in the US
- Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
August 14, 2009
- Supply Shortage Of Cerezyme ? Updated Treatment Recommendations Required
- NEHI Research Shows Patient Medication Nonadherence Costs Health Care System $290 Billion Annually
- FDA MedWatch - CellCept (mycophenolate mofetil) - cases of Pure Red Cell Aplasia reported in patients treated with CellCept
August 17, 2009
August 18, 2009
- U.S. District Court Rules Against Lilly Regarding Gemzar Patent
- Geron's IND for Spinal Cord Injury Placed on Hold
- Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
- Par Pharmaceutical Wins on Invalidity in Ultram ER Litigation
August 19, 2009
- Basilea Pharmaceutica Ltd. (CH) - FDA Issues Warning Letter to Johnson & Johnson Related to Ceftobiprole
- FDA Sends J&J Warning Letter Over Trial Conditions
- PhRMA Statement on Commitment to Health Care Reform
- Mylan Files Lawsuit Against Pittsburgh Post-Gazette
- Merck Wins Singulair Patent Infringement Lawsuit
- Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research
- US Physicians Define Healthcare Reform Platform on Sermo
August 20, 2009
- ZymoGenetics Submits Citizen Petition to FDA Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety
- Secure eHealth License Holder Private Access, Inc. Announces Commercial Beta Release of Privacy-Enhanced Search Technology, Including Collaboration with Pfizer, Inc.
- Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement
August 21, 2009
- FDA Proposes Mandatory Electronic Safety Reporting
- Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc.
- Merck is Pleased the FDA and CDC Re-Affirm the Safety Profile of Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]
- MediciNova and Avigen Enter Into Definitive Agreement for Business Combination
- Off-label use: Oft not evidence based
- Astellas: Reorganization of Drug Discovery Research Functions
- Palio Announces Partnership with Zemoga
- Diabetes drug linked to increased risk of heart failure
August 24, 2009
- FDA Issues Warning Letters to Several, Including Allergan, Galderma Laboratories and Johnson & Johnson Pharmaceutical Research & Development
- UCB Further Strengthens its Second Largest Market, Germany
- Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform
- ARIAD And Its Co-Plaintiffs Announce That the Court of Appeals Granted Their Petition for Rehearing En Banc In the Lilly NF-kB Patent Lawsuit
- Warner Chilcott Acquires P&G's Global Pharmaceuticals Business
August 25, 2009
- FDA Issues Early Communication about Ongoing Safety Review of Weight Loss Drug Orlistat
- Ligand to Acquire Neurogen for Stock and Contingent Value Rights
- GSK Advisory: Warehouse Theft
- MedWatch - Orlistat (marketed as Alli and Xenical): FDA reviewing reports of serious liver injury, including liver failure
- Cambrex Receives FDA Warning Letter
- Study: 3 out of 4 U.S. Nurses Recommend Health Websites to Patients
- Wyeth Continues Research Project Originally Initiated In Collaboration With Karo Bio
- Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
August 26, 2009
August 27, 2009
- FDA Warns About Stolen Insulin
- FDA Sends Johnson & Johnson and Pedinol Pharmacal Warning Letters
- Geron Comments on FDA Hold on Spinal Cord Injury Trial
- Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
- WPP Interim Results 2009
- Filing: Ortho-McNeil Drops Injectable Risperdone Development.
- Pfizer and Astellas Announce Co-promotion Agreement for Caduet Combination Tablets
- Taisho Pharmaceutical: Discontinuation of Development of NT-702 for a Part of Indications
- Bristol-Myers Squibb Completes Initial Tender Offer for Medarex, Inc. with 87.7% of Shares Tendered; Announces Subsequent Offering Period
- Pharmalive.Com Launches New Bioscience Investment Report
